filmov
tv
Considering Treatment for HER2-Negative Breast Cancer
Показать описание
Specifically looking into the human epidermal growth factor receptor 2 (HER2)-negative breast cancer setting, Joyce A. O’Shaughnessy, M.D., considers what treatment options were historically available for patients.
CURE: Combining science and humanity to make cancer understandable.
CURE: Combining science and humanity to make cancer understandable.
Considering Treatment for HER2-Negative Breast Cancer
Treatment Options for HER2-Negative Breast Cancer
Treatment Options for ER/PR Positive or Negative Breast Cancer
Case Study: Treating HR-Positive and HER2-Negative Breast Cancer
Conceptualizing Guidelines to Manage Patients with HR–Positive, HER2-Negative Early Breast Cancer
How to Treat HER2-Positive (HER2+) Breast Cancer: All You Need to Know
Treatments for HR+, HER2-Negative Metastatic Breast Cancer
Dr. Edith Perez on the Etirinotecan Pegol for HER2-Negative Breast Cancer
New and emerging agents in HER2-negative metastatic breast cancer: Implications for practice
BRCA Mutations in HER2-Negative Breast Cancer
Dr. Denduluri on Treatment Approaches in Early-Stage HR+/HER2- Breast Cancer
Kathy S. Albain: Patients with luminal A and B / HER2 negative breast cancer
Study of Palbociclib after CDK & Endocrine Therapy in ER+/HER2- Metastatic Breast Cancer
PI3K inhibitors for the treatment of brain metastases in HER2-negative breast cancer
Updates on hormone receptor-positive HER2-negative breast cancer
For ER PR HER2 Negative Breast Carcinoma avoid these foods and supplements!
Adjuvant therapy for early stage ER-positive, HER2-negative invasive breast cancer
Metastatic Triple Negative Breast Cancer Treatments To Consider
How to Treat Estrogen Receptor-Low Breast Cancer: All You Need to Know
Treating Metastatic ER+ Breast Cancer
Assessing Risk in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: How to Approach Ch...
What is Triple-Negative Breast Cancer, and How is it Treated?
TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment Arsenal
CDK4/6 Inhibitors & Endocrine Therapy in Breast Cancer
Комментарии